Evidence map›Paper›PMID 26031882›Full record

ReviewPhytotherapy research : PTR2015

Anti-diabetic and Anti-hyperlipidemic Effects and Safety of Salacia reticulata and Related Species.

Sidney J Stohs, Sidhartha Ray

Open access · hybridAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 52 citations in OpenAlex.

  1. Journal of diabetes research · 2016
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Foods (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sidney J StohsAdvoCare International, Plano, TX, 75074, USA.
Sidhartha RayDivision of Pharmaceutical Sciences, Manchester University College of Pharmacy, Fort Wayne, IN, 46845, USA.
Manchester University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracts of Salacia reticulata Wight (Hypocrataceae) roots, stems, and leaves have been used in Asia for hundreds of years for the folkloric treatment of diabetes and other health problems. Constituents that have been identified as exhibiting anti-diabetic effects include salacinol, kotalanol, ponkorinol, salaprinol, and their corresponding de-0-sulfonated compounds. Mangiferin, kotalagenin 16-acetate and various proanthocyanidin oligomers have also been isolated. Studies indicate that Salacia extracts modulate multiple targets that influence carbohydrate and lipid metabolism including α-glucosidase, aldose reductase, pancreatic lipase, peroxisomal proliferator-activated receptor-α, glucose transporter-4 mediated glucose uptake, and angiotensin II type 1 receptor. Furthermore, Salacia extracts exhibit free radical scavenging, antioxidant and hepatoprotectant activities. In human studies, Salacia extracts have been shown to decrease plasma glucose and insulin levels, decrease HbA1c, and modulate serum lipid levels with no adverse effects being reported. Similar results have been demonstrated in rat and mouse models as well as in vitro systems. Safety of S. reticulata and other Salacia species as S. oblonga and S. chinensis in rats and mice indicate that extracts are exceedingly safe. No clinical studies have examined the effects of Salacia extracts on human weight loss, although weight loss and decreases in weight gain have been demonstrated in animal models. Because of the large number of pharmacologically active compounds, it is difficult to establish standards for extracts.

Indexed as

AnimalsAntioxidantsCarbohydrate MetabolismDiabetes MellitusHumansHypolipidemic AgentsLipid MetabolismMiceMonosaccharidesPlant ExtractsPlant LeavesPlant RootsProanthocyanidinsRandomized Controlled Trials as TopicRatsSalaciaAntioxidantsHypolipidemic Agentskotalagenin 16-acetateKotalanolmangiferinMonosaccharidesPlant ExtractsproanthocyanidinProanthocyanidinssalacinolSugar AlcoholsSulfatesTriterpenesXanthonesantidiabeticanti-hyperlipidemicantioxidanthepatoprotectantSalacia reticulata

Identifiers

PMID26031882
PMCPMC5033029
OpenAlexW1595489964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.